A Proposed Mechanism for Natural Immunity to Enterobacterial Pathogens
The DOI matches its Crossref record.
Abstract
Summary: The bactericidal effect of normal mouse serum, generally ascribed to natural “O” antibodies, can be removed by absorption with rough microorganisms. Passive hemagglutination tests disclose the presence of thermolabile, non-agglutinating “R” antibodies in normal mouse serum; titers in germ-free animals are much lower. Horse hyperimmune serum against rough S. typhimurium protects mice against infection with unrelated virulent smooth K. pneumoniae. Provided the Klebsiellae are preincubated in normal mouse serum bactericidal activity can also be demonstrated in vitro. This activity does not require the presence of complement and can be removed either by the same Klebsiella strain or by rough strains of Salmonellae but not by the smooth strain of Salmonellae from which these mutants originate. Although these effects would most easily be accounted for by specific antibodies it is also possible that they are instead attributable to a serum protein capable of charge interaction with rough antigens. In any event these findings, together with previous observations concerning degradation of somatic antigen and phenotypic modification of Klebsiellae recovered from endotoxin-treated mice, have led to the development of a new concept of natural immunity to Enterobacteriaceae. In this hypothesis, enzymatic factors capable of attacking cell wall components unmask R antigenic sites common to many bacterial strains and species. Thereafter the presence of a few types of “R” antibodies or of serum factors reacting with rough antigens have the capability of coping, like masterkeys, with a very wide range of infections due to serologically unrelated organisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Bacterial Endotoxins and Host Immune Responses
Morrison, D. C., & Ryan, J. L. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60802-0 · Cited by 613
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Campylobacter Enteritis: Clinical and Epidemiologic Features
BLASER, M. J., BERKOWITZ, I. D., LaFORCE, F. M., CRAVENS, J., RELLER, L. B., & WANG, W.-L. L. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-179 · Cited by 552
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria
Taylor, P. W. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.1.46-83.1983 · Cited by 483
Isolation and Chemical and Immunological Characterization of Bacterial Lipopolysaccharides
LÜDERITZ, O., WESTPHAL, O., STAUB, A. M., & NIKAIDO, H. (1971) · Bacterial Endotoxins · doi:10.1016/b978-0-12-046504-0.50010-3 · Cited by 293
Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine.
(1989) · Europe PMC (PubMed Central) · Cited by 109
Immunity targeting common core antigens of Gram-negative bacteria
Tyler, J. W., Cullor, J. S., Spier, S. J., & Smith, B. P. (1990) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1990.tb00870.x · Cited by 33
Metadata
- Authors
- Chedid, L., Parant, M., Parant, F., & Boyer, F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1968-02-01
- Volume
- 100
- Issue
- 2
- Pages
- 292-301
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1845158209
- Cited by
- 186
- References
- 0
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.